Phase II combination of pemetrexed and oxaliplatin in patients with recurrent non-small cell lung cancer after failure to platinum based adjuvant chemotherapy

Trial Profile

Phase II combination of pemetrexed and oxaliplatin in patients with recurrent non-small cell lung cancer after failure to platinum based adjuvant chemotherapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Oxaliplatin (Primary) ; Pemetrexed (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top